Sotera Health (NASDAQ: SHC) issues 2025 preliminary revenue update

Rhea-AI Filing Summary

Sotera Health Company furnished an update with preliminary revenue results for full-year 2025. The company issued a press release on January 12, 2026 summarizing approximate revenue based on information available as of that date. These preliminary figures are still subject to completion of year-end closing procedures and audit by the independent registered public accounting firm, and the company notes that the approximation falls within the guidance provided at the time of its third quarter earnings release.

The update also notes that management is delivering a business update at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026. A slide presentation and webcast link or replay can be accessed through the Investor Relations section of the company’s website. The information about preliminary results and the conference presentation is being furnished, not filed, and is not automatically incorporated into other securities law filings.

0001822479FALSE00018224792026-01-122026-01-12

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_______________________

FORM 8-K

_______________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): January 12, 2026

_______________________

SOTERA HEALTH COMPANY

(Exact Name of Registrant as Specified in its Charter)

_______________________

Delaware

001-39729

47-3531161

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)

9100 South Hills Blvd, Suite 300

Broadview Heights, Ohio 44147

(Address of Principal Executive Offices) (Zip Code)

(440) 262-1410

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

_______________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol

Name of Exchange on which registered

Common stock, $0.01 par value per share

SHC

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company   ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 2.02. Results of Operations and Financial Condition.

The information under the heading “Preliminary Financial Results” under Item 7.01, including the press release announcing preliminary revenue results for Sotera Health Company (the “Company”) for full-year 2025 (the “Press Release”), is incorporated by reference into this Item 2.02.

Item 7.01. Regulation FD Disclosure.

Preliminary Financial Results

On January 12, 2026, the Company issued the Press Release. A copy of the Press Release is attached hereto as Exhibit 99.1.

The preliminary revenue results are based on information available to the Company as of January 12, 2026 and are subject to completion of the Company’s year-end financial closing procedures and audit by the Company’s independent registered public accounting firm. The approximation of revenue included in the Press Release is within the guidance provided at the time of the Company’s third quarter earnings release.

J.P. Morgan Healthcare Conference Presentation

As previously announced on January 7, 2026, management will deliver a business update at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026 at approximately 1:30 p.m. Eastern Time. A copy of the Company’s slide presentation and a link to the live presentation, or a replay of the webcast of the presentation, may be accessed via the Investor Relations section of the Company’s website.

The information in Item 2.02 and Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liability under that section, and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, unless expressly incorporated by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number						Description
99.1						Press Release, dated January 12, 2026
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			Sotera Health Company (Registrant)
Date: January 12, 2026			By:						/s/ Jonathan M. Lyons
									Jonathan M. Lyons
									Senior Vice President and Chief Financial Officer

FAQ

What did Sotera Health (SHC) disclose in this Form 8-K?

Sotera Health Company furnished an update containing preliminary revenue results for full-year 2025, communicated through a press release dated January 12, 2026, and referenced that these results are based on information available as of that date.

Are Sotera Health’s preliminary 2025 revenue results final?

No. The company states that the preliminary revenue results are subject to completion of year-end financial closing procedures and audit by its independent registered public accounting firm.

How do the preliminary 2025 revenue results compare to Sotera Health’s prior guidance?

The company notes that the approximation of revenue in the press release is within the guidance it provided at the time of its third quarter 2025 earnings release.

What is Sotera Health’s involvement in the J.P. Morgan Healthcare Conference?

Management is delivering a business update at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026 at approximately 1:30 p.m. Eastern Time.

Where can investors access Sotera Health’s conference presentation and webcast?

The company states that a slide presentation and a link to the live or replay webcast of the J.P. Morgan Healthcare Conference presentation are available via the Investor Relations section of its website.

Is the preliminary financial information considered filed with the SEC?

No. The company specifies that the information in Item 2.02 and Item 7.01, including the press release, is furnished and not deemed filed under the Securities Exchange Act of 1934, and is not incorporated into other filings unless expressly referenced.